{"id":775086,"date":"2023-08-03T11:42:47","date_gmt":"2023-08-03T15:42:47","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/generation-bio-to-present-at-the-canaccord-genuity-43rd-annual-growth-conference\/"},"modified":"2023-08-03T11:42:47","modified_gmt":"2023-08-03T15:42:47","slug":"generation-bio-to-present-at-the-canaccord-genuity-43rd-annual-growth-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/generation-bio-to-present-at-the-canaccord-genuity-43rd-annual-growth-conference\/","title":{"rendered":"Generation Bio to Present at the Canaccord Genuity 43rd Annual Growth Conference\u00a0"},"content":{"rendered":"
\n

CAMBRIDGE, Mass., Aug. 03, 2023 (GLOBE NEWSWIRE) — Generation Bio Co.<\/u><\/a> (Nasdaq:GBIO), a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, announced that Matt Norkunas, M.D., chief financial officer, will present at the 2023 Canaccord Healthcare Conference on Thursday, August 10, 2023 at 11:00 a.m. ET in Boston.\u00a0 \u00a0<\/p>\n

A live webcast of the presentation will be available on the investor section of the company\u2019s website at investors.generationbio.com<\/u><\/a>. A replay will be available there for 30 days following the event.\u00a0\u00a0
\u202f\u00a0
About Generation Bio\u202f<\/strong>\u202f\u00a0
Generation Bio is innovating genetic medicines to provide durable, redosable treatments for people living with rare and prevalent diseases. The company\u2019s non-viral genetic medicine platform incorporates a novel DNA construct called closed-ended DNA, or ceDNA; a unique cell-targeted lipid nanoparticle delivery system, or ctLNP; and a highly scalable capsid-free manufacturing process that uses proprietary cell-free rapid enzymatic synthesis, or RES, to produce ceDNA. This approach is designed to enable multi-year durability from a single dose, to deliver large genetic payloads, including multiple genes, to specific tissues and cell types, and to allow titration and redosing to adjust or extend expression levels in each patient. RES has the potential to expand Generation Bio\u2019s manufacturing scale to hundreds of millions of doses to support its mission to extend the reach of genetic medicine to more people, living with more diseases, around the world.\u202f\u202f\u00a0<\/p>\n

For more information, please visit www.generationbio.com<\/u>.<\/a>\u202f\u202f\u00a0
\u202f\u202f\u00a0
Investors\u202fand Media Contact<\/strong>\u202f\u00a0
Maren Killackey\u202f\u00a0
Generation Bio\u202f\u00a0
mkillackey@generationbio.com<\/u><\/a>\u202f\u00a0
857-371-4638\u202f\u00a0
\u202f\u00a0<\/p>\n

\u00a0<\/p>\n


\n
\n \n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

CAMBRIDGE, Mass., Aug. 03, 2023 (GLOBE NEWSWIRE) — Generation Bio Co. (Nasdaq:GBIO), a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, announced that Matt Norkunas, M.D., chief financial officer, will present at the 2023 Canaccord Healthcare Conference on Thursday, August 10, 2023 at 11:00 a.m. ET in Boston.\u00a0 \u00a0 A live webcast of the presentation will be available on the investor section of the company\u2019s website at investors.generationbio.com. A replay will be available there for 30 days following the event.\u00a0\u00a0\u202f\u00a0About Generation Bio\u202f\u202f\u00a0Generation Bio is innovating genetic medicines to provide durable, redosable treatments for people living with rare and prevalent diseases. The company\u2019s non-viral genetic medicine platform incorporates a novel DNA construct called closed-ended DNA, or … <\/p>\n

Continue reading “Generation Bio to Present at the Canaccord Genuity 43rd Annual Growth Conference\u00a0“<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-775086","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nGeneration Bio to Present at the Canaccord Genuity 43rd Annual Growth Conference\u00a0 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/generation-bio-to-present-at-the-canaccord-genuity-43rd-annual-growth-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Generation Bio to Present at the Canaccord Genuity 43rd Annual Growth Conference\u00a0 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"CAMBRIDGE, Mass., Aug. 03, 2023 (GLOBE NEWSWIRE) — Generation Bio Co. (Nasdaq:GBIO), a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, announced that Matt Norkunas, M.D., chief financial officer, will present at the 2023 Canaccord Healthcare Conference on Thursday, August 10, 2023 at 11:00 a.m. ET in Boston.\u00a0 \u00a0 A live webcast of the presentation will be available on the investor section of the company\u2019s website at investors.generationbio.com. A replay will be available there for 30 days following the event.\u00a0\u00a0\u202f\u00a0About Generation Bio\u202f\u202f\u00a0Generation Bio is innovating genetic medicines to provide durable, redosable treatments for people living with rare and prevalent diseases. The company\u2019s non-viral genetic medicine platform incorporates a novel DNA construct called closed-ended DNA, or … Continue reading "Generation Bio to Present at the Canaccord Genuity 43rd Annual Growth Conference\u00a0"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/generation-bio-to-present-at-the-canaccord-genuity-43rd-annual-growth-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-08-03T15:42:47+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg4NjQzOCM1NzM0ODYxIzIxOTY5Mjg=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/generation-bio-to-present-at-the-canaccord-genuity-43rd-annual-growth-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/generation-bio-to-present-at-the-canaccord-genuity-43rd-annual-growth-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Generation Bio to Present at the Canaccord Genuity 43rd Annual Growth Conference\u00a0\",\"datePublished\":\"2023-08-03T15:42:47+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/generation-bio-to-present-at-the-canaccord-genuity-43rd-annual-growth-conference\\\/\"},\"wordCount\":262,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/generation-bio-to-present-at-the-canaccord-genuity-43rd-annual-growth-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODg4NjQzOCM1NzM0ODYxIzIxOTY5Mjg=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/generation-bio-to-present-at-the-canaccord-genuity-43rd-annual-growth-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/generation-bio-to-present-at-the-canaccord-genuity-43rd-annual-growth-conference\\\/\",\"name\":\"Generation Bio to Present at the Canaccord Genuity 43rd Annual Growth Conference\u00a0 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/generation-bio-to-present-at-the-canaccord-genuity-43rd-annual-growth-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/generation-bio-to-present-at-the-canaccord-genuity-43rd-annual-growth-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODg4NjQzOCM1NzM0ODYxIzIxOTY5Mjg=\",\"datePublished\":\"2023-08-03T15:42:47+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/generation-bio-to-present-at-the-canaccord-genuity-43rd-annual-growth-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/generation-bio-to-present-at-the-canaccord-genuity-43rd-annual-growth-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/generation-bio-to-present-at-the-canaccord-genuity-43rd-annual-growth-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODg4NjQzOCM1NzM0ODYxIzIxOTY5Mjg=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODg4NjQzOCM1NzM0ODYxIzIxOTY5Mjg=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/generation-bio-to-present-at-the-canaccord-genuity-43rd-annual-growth-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Generation Bio to Present at the Canaccord Genuity 43rd Annual Growth Conference\u00a0\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Generation Bio to Present at the Canaccord Genuity 43rd Annual Growth Conference\u00a0 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/generation-bio-to-present-at-the-canaccord-genuity-43rd-annual-growth-conference\/","og_locale":"en_US","og_type":"article","og_title":"Generation Bio to Present at the Canaccord Genuity 43rd Annual Growth Conference\u00a0 - Market Newsdesk","og_description":"CAMBRIDGE, Mass., Aug. 03, 2023 (GLOBE NEWSWIRE) — Generation Bio Co. (Nasdaq:GBIO), a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, announced that Matt Norkunas, M.D., chief financial officer, will present at the 2023 Canaccord Healthcare Conference on Thursday, August 10, 2023 at 11:00 a.m. ET in Boston.\u00a0 \u00a0 A live webcast of the presentation will be available on the investor section of the company\u2019s website at investors.generationbio.com. A replay will be available there for 30 days following the event.\u00a0\u00a0\u202f\u00a0About Generation Bio\u202f\u202f\u00a0Generation Bio is innovating genetic medicines to provide durable, redosable treatments for people living with rare and prevalent diseases. The company\u2019s non-viral genetic medicine platform incorporates a novel DNA construct called closed-ended DNA, or … Continue reading \"Generation Bio to Present at the Canaccord Genuity 43rd Annual Growth Conference\u00a0\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/generation-bio-to-present-at-the-canaccord-genuity-43rd-annual-growth-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2023-08-03T15:42:47+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg4NjQzOCM1NzM0ODYxIzIxOTY5Mjg=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/generation-bio-to-present-at-the-canaccord-genuity-43rd-annual-growth-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/generation-bio-to-present-at-the-canaccord-genuity-43rd-annual-growth-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Generation Bio to Present at the Canaccord Genuity 43rd Annual Growth Conference\u00a0","datePublished":"2023-08-03T15:42:47+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/generation-bio-to-present-at-the-canaccord-genuity-43rd-annual-growth-conference\/"},"wordCount":262,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/generation-bio-to-present-at-the-canaccord-genuity-43rd-annual-growth-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg4NjQzOCM1NzM0ODYxIzIxOTY5Mjg=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/generation-bio-to-present-at-the-canaccord-genuity-43rd-annual-growth-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/generation-bio-to-present-at-the-canaccord-genuity-43rd-annual-growth-conference\/","name":"Generation Bio to Present at the Canaccord Genuity 43rd Annual Growth Conference\u00a0 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/generation-bio-to-present-at-the-canaccord-genuity-43rd-annual-growth-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/generation-bio-to-present-at-the-canaccord-genuity-43rd-annual-growth-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg4NjQzOCM1NzM0ODYxIzIxOTY5Mjg=","datePublished":"2023-08-03T15:42:47+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/generation-bio-to-present-at-the-canaccord-genuity-43rd-annual-growth-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/generation-bio-to-present-at-the-canaccord-genuity-43rd-annual-growth-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/generation-bio-to-present-at-the-canaccord-genuity-43rd-annual-growth-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg4NjQzOCM1NzM0ODYxIzIxOTY5Mjg=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg4NjQzOCM1NzM0ODYxIzIxOTY5Mjg="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/generation-bio-to-present-at-the-canaccord-genuity-43rd-annual-growth-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Generation Bio to Present at the Canaccord Genuity 43rd Annual Growth Conference\u00a0"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/775086","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=775086"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/775086\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=775086"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=775086"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=775086"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}